Bovine anaplasmosis caused by the intraerythrocytic rickettsial pathogen Anaplasma marginale is endemic in South Africa. Anaplasma marginale subspecies centrale also infects cattle; however, it causes a milder form of anaplasmosis and is used as a live vaccine against A. marginale. There has been less interest in the epidemiology of A. marginale subsp. centrale, and, as a result, there are few reports detecting natural infections of this organism. When detected in cattle, it is often assumed that it is due to vaccination, and in most cases, it is reported as coinfection with A. marginale without characterization of the strain. A total of 380 blood samples from wild ruminant species and cattle collected from biobanks, national parks, and other regions of South Africa were used in duplex real-time PCR assays to simultaneously detect A. marginale and A. marginale subsp. centrale. PCR results indicated high occurrence of A. marginale subsp. centrale infections, ranging from 25 to 100% in national parks. Samples positive for A. marginale subsp. centrale were further characterized using the msp1aS gene, a homolog of msp1␣ of A. marginale, which contains repeats at the 5= ends that are useful for genotyping strains. A total of 47 Msp1aS repeats were identified, which corresponded to 32 A. marginale subsp. centrale genotypes detected in cattle, buffalo, and wildebeest. RepeatAnalyzer was used to examine strain diversity. Our results demonstrate a diversity of A. marginale subsp. centrale strains from cattle and wildlife hosts from South Africa and indicate the utility of msp1aS as a genotypic marker for A. marginale subsp. centrale strain diversity.
Bovine anaplasmosis (gallsickness) is a tick-borne disease caused by the intraerythrocytic rickettsial pathogen Anaplasma marginale (1). A. marginale is globally prevalent and results in anemia, with mortality rates of up to 30% (2). Anaplasma marginale subspecies centrale is a less virulent subspecies detected by Sir Arnold Theiler, who recognized its potential as a vaccine against anaplasmosis; 100 years later this live vaccine is still in use in South Africa, Israel, South America, and Australia (3, 4). The strain that is used as a vaccine originated from Theiler's original isolation and was exported at various times to other countries where it has been propagated in the laboratory; the strain known as the "Israel strain" or the "vaccine strain" was sent to Israel in the 1950s and was used to generate the complete genome sequence for A. marginale subsp. centrale in 2010 (5). A. marginale subsp. centrale does not provide complete protection against A. marginale infection but does protect against severe anaplasmosis (6, 7). (8)(9)(10)(11). Cattle are naturally susceptible to A. marginale (4). There has not been much interest in the epidemiology of A. marginale subsp. centrale, with few reports detecting natural infections of this organism; most often, when detected in cattle it is assumed that it is due to vaccination and is reported as coinfection with A. marginale without...